Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine Dependence

GR is not a cancer-specific vulnerability, while MR is. Therefore, GR is not a promising cancer-therapy strategy.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2026-01-30
DOI
https://doi.org/10.21873/anticanres.17984
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine Dependence

Yasunori Tome, KOHEI MIZUTA, Byung Mo Kang, YUTA MIYASHI et al.
Anticancer Research
Cancer Research and Treatments
article

Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine Dependence

Yasunori Tome, KOHEI MIZUTA, Byung Mo Kang, YUTA MIYASHI, JIN SOO KIM, KOTARO NISHIDA, YOHEI ASANO, ROBERT M. HOFFMAN, QINGHONG HAN, Shukuan Li, Michael Bouvet
article en

Abstract

GR is not a cancer-specific vulnerability, while MR is. Therefore, GR is not a promising cancer-therapy strategy.

Anticancer ResearchVol. 46(2)
University of the Ryukyus (JP), University of California San Diego (US), AntiCancer (United States) (US)
Openalex Percentile: Top 75%
Cancer Research and Treatments
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.